Trump hints possible retaliation if India does not export anti-malaria drug used in coronavirus treatment

DY365
DY365
Published: April 7,2020 01:54 PM
DY365

Story highlights

April 7, 2020: US President Donald Trump hints at a possible retaliation if India does not lift its hold on the export of Hydroxychloroquine, the anti-malaria drug used in the treatment of coronavirus

April 7, 2020: US President Donald Trump hints at a possible retaliation if India does not lift its hold on the export of Hydroxychloroquine, the anti-malaria drug used in the treatment of coronavirus patients.



President Trump made the request for releasing the hold on hydroxychloroquine in a phone call with Prime Minister Narendra Modi Sunday morning (evening in India).



"After call today with Indian Prime Minister Narendra Modi, India is giving serious consideration to releasing the hold it put on a US order for hydroxychloroquine," Trump announced.



Trump speaking from the White House during the Coronavirus taskforce briefing said that India does very well with the US and he sees no reason why India would not lift the hold on the US order of the medicine.



"I said we'd appreciate you allowing our supply to come out, if he doesn't allow it to come out. That would be okay but, of course, there may be retaliation," the President said at the daily White House briefing on the coronavirus outbreak, adding, rhetorically for stress, "Why wouldn't that be?"



The American leader went on to add to the threat his long-running grievances with India on trade issues, which have history of eluding resolution, including an ultimately failed rush by the two countries to stitch together a deal in time for Trump's first state visit to India in February. This was the first time he had publicly brought up trade after the visit.